Redefining precision screening for early cancer detection
Precision screening to find the risk of cancer early
National repository for human genetic resources
It has entered into a comprehensive strategic cooperation framework with the Wuhan BioBank, one of only four national human genetic resources banks in China, and has successfully established a presence.
Global Testing Service Center
Timingbio operates a Laboratory developed tests（LDT） in Wuhan. These facilities are designed to meet the standards for NGS sequencing laboratories, enabling a maximum sample detection capacity of up to 20 million cases per year.
Numerous scientific research accomplishments
The company's scientific and technological accomplishments have garnered widespread recognition. Several key products have obtained EU CE certification, and the company holds over a dozen core independent intellectual property rights in the United States, Europe, China, and other regions.
To prevent the global health threat posed by cancer.
Innovation in science and technology —— The inception of 'rbcDNA'
Termed as the 'The most skilled physicians can make diagnoses of diseases prior to the onset of symptoms,' this rbcDNA detection technology accurately identifies a range of common diseases and malignant tumors in their early stages.
In 2021, Dr. Gao Xiaofei, the founder of Timingbio, introduced and validated the pioneering concept of early disease detection through analysis of residual DNA in micronuclei of red blood cells.
License for medical institution practice
The rbcDNA kit has received EU CE certification.
Numerous proprietary intellectual property rights
The science and technology small and medium-sized enterprises in Zhejiang Province
Possess a medical institution license approved for independent medical laboratory operations.
Subject to ongoing evaluation and oversight by national authorities, products are granted approval for EU CE certification.
It is involved in various national and provincial research initiatives, including national key research and development projects
Granted the 'Young Eagle Program', the pilot enterprise '5213'
Honor and qualification
Cooperative partner
News
地址：杭州市萧山经济开发区杭州湾信息港
邮箱：timingbio@timingbio.com
关注或联系
添加太铭生物公众号、或访问健康严选线上检测商城
太铭生物 版权所有 浙ICP备19009517号-2
|
|